Background: Patent ductus arteriosus (PDA) is highly prevalent in extremely low birth weight (ELBW), preterm infants. There are diverse management approaches for the PDA in ELBW infants. The objectives of this research were to identify current
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| INTRODUC TI ON
A Patent ductus arteriosus (PDA) is found in 40-60% of extremely low birth weight (ELBW-birth weight < 1 kg), preterm infants. 1 Yet, neither is there a consensus on managing ELBW infants with a PDA, 2 nor do we know which infant will benefit from treatment.
2-4
Incidences of necrotizing enterocolitis (NEC), chronic lung disease (CLD), and intraventricular hemorrhage (IVH) are associated with PDA, [5] [6] [7] as pulmonary over circulation occurs and systemic circulation is hypoperfused. 6, 7 Management practices can vary from watchful waiting for closure, medical therapy with Cox inhibitors, surgical ligation, 3 and transcatheter PDA closure (TCPC). [8] [9] [10] [11] This article presents some of the considerations which determine the modality and timing of PDA treatment, if any, from a sample of 100 prominent cardiologists and neonatologists in the United States.
We aimed to identify practice variations among prominent neonatologists in the United States and also to contrast with cardiologists' opinions.
| ME THODS
Approval for this study and the survey was obtained from the and was sent via group emails. The survey was sent out to several prominent neonatologists and cardiologists in the United States.
Both groups received the same survey questions and responses to choose, except, the cardiologists had an additional tenth question.
The same survey with 10 questions was also emailed to a group of interventional cardiologists who perform TCPC. The participants had the option to skip responding to a question, if they were unsure of the correct response. The survey was closed when responses were obtained from approximately 100 prominent neonatologist and 100 prominent cardiologists in the United States. Since, the survey to the general cardiologists and the interventional cardiologists were sent out simultaneously, we closed the survey when 50 of each had responded.
The survey was also conducted among the attendees of the First 
| Statistical methods
The individual responses to each survey question were represented 
| RE SULTS
There were exactly 100 prominent neonatologists from 74 centers and 103 prominent cardiologists from 75 centers that responded to the email survey. Some had skipped responding to a few questions. Figure 2) Roughly half of the neonatologists responded that they will attempt two courses of medical therapy before referring for an invasive alternative. This was echoed by 55% of the cardiologists and 71% of the conference attendees (P = NS). Interestingly, 8% of the neonatologists in the country responded that they would not seek other forms of therapy if medical therapy failed; while, 6% of the neonatologists responded that they would not even attempt medical therapy to close the PDA. Twenty-three percent of the neonatologists responded that they will not refer for either surgical or transcatheter PDA closure if medical therapy failed vs only 5% of cardiologists who responded that they will forego any further intervention to close the PDA (P < .001).
Interestingly, all conference goers preferred some form of interven- This question allowed the responders to pick more than one response. Thirty-six percent of neonatologists and 16% of cardiologists TA B L E 1 At your institute, what best describes the routine clinical practice for medical management of a Large PDA in a premature baby born <28 weeks of gestation?
Survey question

Neonatologists
N = 94
Cardiologists N = 96 P value
PDA Symposium N = 152
Prophylactic medical therapy starting in the first week of life 10% (n = 9) 15% (n = 14)
.375 4% (n = 6)
ECHO directed therapy regardless of symptoms within the first week of life
ECHO directed therapy regardless of symptoms after the first week of life 10% (n = 9) 9% (n = 9) 1 12% (n = 17)
Symptomatic therapy after the first week of life 65% (n = 61) 66% (n = 63) 1 79% (n = 120)
We believe that PDA never requires treatment 5% (n = 5) 0% (n = 0) .028 a 2% (n = 3)
Primary surgical or catheter-based PDA closure
a Statististically significant.
F I G U R E 1 Survey results for Question 1
were unaware that TCPC was feasible in ELBW infants. Interestingly, cardiologists were more concerned than the neonatologists (18% vs 58%, P < .001) regarding femoral arterial injury during TCPC, even though this procedure does not entail utilizing the femoral artery for access.
Question 6.
At what age do you think the PDA must be closed for best patient outcome in someone born <28 weeks' gestation? ( Table 6 and Figure 6 )
Thirty-four percent of neonatologists responded that the PDA in this population does not need to be closed. Only 8% of the cardiologists agreed (P < .001). At least one-quarter of the cardiologists responded that the PDA must be closed within the first month of life, compared to 10% of the neonatologists (P = .005). Almost 50% of the conference attendees agreed that the PDA must be closed within the first month of life.
Question 7. In your opinion, what is the ideal time to perform tran-
scatheter PDA Closure in someone born <28 weeks' gestation? ( Table 7 and Figure 7 )
Twenty-four percent of the neonatologists felt that TCPC is never needed for these patients. Twenty-five percent of cardiologists felt that the best time to perform TCPC was between weeks 2-4 of life.
However, only 11% of the neonatologists agreed (P = .014). After attending the conference, 67% agreed that the ideal timing for TCPC in between 2-4 weeks of age.
Question 8. In your opinion what is the lowest weight of a child in
whom transcatheter PDA closure can be safely performed? ( Table 8 and Figure 8 )
Majority of cardiologists (24%) felt that TCPC can be safely performed in children over 1 kg, whereas, the majority of Neonatologists (31%) responded that the ideal weight to perform TCPC would be greater than 2 kg. After attending the symposium, 67% of the attendees were convinced that the procedure can be performed in children weighing between 500-1000 grams.
Question 9.
In your opinion and experience, does closing a hemodynamically significant PDA make a difference in morbidity and mortality for children born <28 weeks' gestation? ( Table 9 and Figure 9 )
As expected, 88% of cardiologists responded that closing the PDA will improve outcomes of ELBW infants compared to only 54% of neonatologists (P < .001). Following the conference, 97% of the combined, potentially biased audience agreed that PDA closure will benefit this vulnerable group of children. This question was only for the cardiologists. Therefore, no statistic comparisons were performed. Forty-seven percent of the cardiologists responded that they do not perform TCPC in anyone <2
kg. Among those who do close PDAs in children less than 2 kg, 32%
perform <5 in a year. Only 5% of the centers perform this procedure
Survey question
Neonatologists N = 100 Cardiologists N = 103 P value PDA Symposium N = 148
Three 27% (n = 27) 29% (n = 30) .757 17% (n = 25)
More than three attempts 2% (n = 2) 4% (n = 4) .683 10% (n = 15)
We do not refer patients for surgical PDA ligation or transcatheter PDA closure
.107 0% (n = 0)
We do not use medical therapy to attempt PDA closure in the first place 6% (n = 6) 2% (n = 2) .166 2% (n = 3)
25-50 times a year and only one center performs >50 TCPC in children <2 kg each year.
| D ISCUSS I ON
The survey identified areas in which cardiologists and neonatologists agreed, and also pointed out areas where there are signifi- and cardiology (63%)) over TCPC (neonatology (13%) and cardiology (32%), P = .001), while watchful waiting was selected as the preferred response by 23% of neonatologists and only 5% of cardiologists (P = .001, Table 4 ). Among those who were surveyed, 36%
TA B L E 3 At your institute, what is the primary indication for referring a neonate born <28 weeks for surgical PDA ligation or transcatheter PDA closure?
Survey question
Neonatologists
N = 99
Cardiologists N = 102 P value
PDA Symposium N = 151
A clinically significant PDA after failure of medical therapy 71% (n = 70) 84% (n = 86) .019 a 80% (n = 121)
Echocardiographic evidence of a large PDA following attempted medical therapy 12% (n = 12) 12% (n = 12) 1 18% (n = 27)
We do not believe PDA in the premature has to be closed either by medications, surgery, or transcatheter therapy as they will eventually all close 14% (n = 14) 1% (n = 1) <.001 a 0% (n = 0)
We do not have access to either surgical PDA ligation or transcatheter PDA closure. Therefore, we do not refer
We would refer if we had access to either surgical PDA ligation or transcatheter PDA closure
We do not attempt medical therapy and primarily perform surgical or transcatheter PDA closure
F I G U R E 3
Survey results for Question 3
of neonatologists were unaware that it is feasible to perform TCPC in ELBW infants.
Survey results identified predominant concerns about transcatheter PDA closure, highlighting areas for future training about associated risks, and post-catheterization patient management ( Technical difficulty in performing the procedure in small infants 44% (n = 42) 48% (n = 47) .568 23% (n = 33) Not aware of this procedure being an option for small preterm neonates 36% (n = 35) 16% (n = 16) .002 a 9% (n = 13)
Radiation exposure 8% (n = 8) 6% (n = 6) .591 5% (n = 7)
Injection of contrast agents 6% (n = 6)
No concerns 13% (n = 12) 6% (n = 6) .144 9% (n = 13) a Statististically significant. weight to perform TCPC would be greater than 2 kg. A fourth of cardiologists felt that the best time to perform TCPC was between weeks 2-4 of life; though only 11% of the neonatologist concurred.
F I G U R E 5
Although statistical analysis was not reported for responses from attendees of the PDA Symposium where both neonatologists and cardiologists were represented, the answers are more unified.
The International PDA Symposium was able to change opinions of the attendees. After attending the conference, 67% agreed that the ideal timing for TCPC in between 2-4 weeks of age, 67% of the attendees were convinced that the procedure can be performed in children weighing between 500-1000 grams, and 97% were convinced that closing the PDA will improve outcomes of these critically ill newborns. Continued discussion and education about closing PDA has the potential to facilitate more of a consensus regarding best management practices.
There is ongoing debate on how to manage PDA in preterm infants. 2, 3, 14, 15 As illustrated in this survey, 50% of the neonatologists are unsure of potential benefits of PDA closure in ELBW infants.
This skepticism could be secondary to the fact that there has been no good treatment options so far. Medical therapy is at best 50% effective in children born 23-26 weeks' gestation 16 and surgical ligation cause unwanted complications secondary to the thoracotomy, conceivably more data are needed about outcomes of TCPC, as it may shift the discussion regarding benefits of closing PDA using this method. TCPC is a relatively new technique that is constantly being refined for the purpose of performing this procedure safely in ELBW infants. Among the many advantages of TCPC over medical therapy is that it guarantees definitive closure of the PDA with limited risks (as low as 3% in some reports in ELBW infants). 17 Since, no "cutting and stitching" of the baby is required unlike surgical ligation, it can prevent complications associated with thoracotomy including post-ligation syndrome. 17 Since this is a new therapy, awareness among neonatologists regarding the feasibility and safety of this technique is still lacking. Events such
TA B L E 6
At what age do you think the PDA must be closed for best patient outcome in someone born <28 weeks' gestation?
Survey question Neonatologists N = 99
Cardiologists N = 101 P value PDA Symposium N = 149
In the first 2 weeks of age 9% (n = 9) 14% (n = 14)
.376 22% (n = 33)
Before a month of age 10% (n = 10) 26% (n = 26) . .071 0% (n = 0) a Statististically significant.
TA B L E 9
In your opinion and experience, does closing a hemodynamically significant PDA make a difference in morbidity and mortality for children born <28 weeks' gestation? Any weight 3% (n = 3) 9% (n = 9) .137 13% (n = 19) 500-1000 g 8% (n = 7) 17% (n = 17) .079 67% (n = 97) >1 kg 15% (n = 14) 24% (n = 24) .148 20% (n = 29)
.028 a 0% (n = 0) >3 kg 11% (n = 10) 8% (n = 8) .622 0% (n = 0) >5 kg 9% (n = 8) 9% (n = 9) 1 0% (n = 0) a Statististically significant.
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as the International PDA Symposium could help educate referring specialists. Given the potential benefits of TCPC over more standard therapies for PDA, we suspect that the role of TCPC in ELBW infants will grow steadily. However, the most important question in the mind of most neonatologists is whether the PDA needs to be closed at all as illustrated by the survey results. Perhaps a randomized control trial comparing TCPC vs observation alone could lay this concern to rest. Interventional cardiologists who currently perform or strive to perform TCPC in ELBW infants must maintain equipoise between boldness and commonsense. If proven to be safe and beneficial, TCPC may eventually find its way into the management algorithm of ELBW infants around the world.
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